(VIANEWS) – PIMCO Income Strategy Fund Shares of Beneficial Interest (PFL), Gilead Sciences (GILD), Huntsman Corporation (HUN) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. PIMCO Income Strategy Fund Shares of Beneficial Interest (PFL)
218.81% Payout Ratio
PIMCO Income Strategy Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in fixed income markets across the globe. The fund invests in a diversified portfolio of floating rate debt instruments with an average duration of around three years. It employs fundamental analysis with top-down approach to create its portfolio. The fund was formerly known as PIMCO Floating Rate Income Fund. PIMCO Income Strategy Fund was formed on June 19, 2003 and is domiciled in the United States.
Earnings Per Share
As for profitability, PIMCO Income Strategy Fund Shares of Beneficial Interest has a trailing twelve months EPS of $0.47.
PE Ratio
PIMCO Income Strategy Fund Shares of Beneficial Interest has a trailing twelve months price to earnings ratio of 17.43. Meaning, the purchaser of the share is investing $17.43 for every dollar of annual earnings.
2. Gilead Sciences (GILD)
66.52% Payout Ratio
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Gilead Sciences has a trailing twelve months EPS of $4.42.
PE Ratio
Gilead Sciences has a trailing twelve months price to earnings ratio of 17.43. Meaning, the purchaser of the share is investing $17.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.11%.
Yearly Top and Bottom Value
Gilead Sciences’s stock is valued at $77.05 at 14:23 EST, way below its 52-week high of $89.74 and way above its 52-week low of $59.27.
Moving Average
Gilead Sciences’s value is below its 50-day moving average of $77.58 and under its 200-day moving average of $80.44.
3. Huntsman Corporation (HUN)
61.19% Payout Ratio
Huntsman Corporation manufactures and sells differentiated organic chemical products worldwide. The company operates through four segments: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyols, thermoplastic polyurethane, propylene oxide, and methyl tertiary-butyl ether products. The Performance Products segment manufactures amines and maleic anhydrides, including ethylene oxide, propylene oxide, glycols, ethylene dichloride, caustic soda, ammonia, hydrogen, methylamines, and acrylonitrile. The Advanced Materials segment offers epoxy, acrylic, polyurethane, and acrylonitrile-butadiene-based polymer formulations; high performance thermoset resins, curing agents and toughening agents, and carbon nanotubes additives; and base liquid and solid resins. The Textile Effects segment provides textile chemicals and dyes. The company's products are used in a range of applications, including adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals, and dye industries. Huntsman Corporation was founded in 1970 and is headquartered in The Woodlands, Texas.
Earnings Per Share
As for profitability, Huntsman Corporation has a trailing twelve months EPS of $1.4.
PE Ratio
Huntsman Corporation has a trailing twelve months price to earnings ratio of 20.47. Meaning, the purchaser of the share is investing $20.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.81%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 26.7%, now sitting on 7.44B for the twelve trailing months.
Yearly Top and Bottom Value
Huntsman Corporation’s stock is valued at $28.66 at 14:23 EST, way under its 52-week high of $33.46 and way higher than its 52-week low of $23.53.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Huntsman Corporation’s EBITDA is 45.21.
Moving Average
Huntsman Corporation’s worth is way higher than its 50-day moving average of $25.82 and higher than its 200-day moving average of $27.53.
4. Luxfer Holdings PLC (LXFR)
57.78% Payout Ratio
Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications. It operates in two segments, Gas Cylinders and Elektron. The Gas Cylinders segment manufactures and markets aluminum, titanium, and carbon composite cylinders, which are used for self-contained breathing apparatus that are used by firefighters and other emergency-responders, as well as scuba divers and personnel in potentially hazardous environments, such as mines; and aluminum and composite cylinders for use in the containment of oxygen and other medical gases that are used by patients, healthcare facilities, and laboratories. This segment also offers carbon composite cylinders for compressed natural gas and hydrogen containment in alternative fuel vehicles; lightweight aluminum cylinders for a variety of industrial applications, such as fire extinguishers and containment of high-purity specialty gases; and lightweight aluminum and titanium panels primarily for use in the aerospace and luxury-auto industries. The Elektron segment focuses on specialty materials based on magnesium, zircon sand, and rare earths. It develops and manufactures magnesium alloys; magnesium powders; and magnesium, copper, and zinc photoengraving plates for graphic arts and luxury packaging. This segment also develops and manufactures zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and other performance products. Luxfer Holdings PLC has operations in the United States, the United Kingdom, Germany, Italy, France, rest of Europe, the Asia Pacific, Canada, South America, Latin America, and Africa. The company was founded in 1898 and is headquartered in Manchester, the United Kingdom.
Earnings Per Share
As for profitability, Luxfer Holdings PLC has a trailing twelve months EPS of $0.92.
PE Ratio
Luxfer Holdings PLC has a trailing twelve months price to earnings ratio of 14.61. Meaning, the purchaser of the share is investing $14.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.79%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 12, 2023, the estimated forward annual dividend rate is 0.52 and the estimated forward annual dividend yield is 3.92%.
5. Tortoise Energy Infrastructure Corporation (TYG)
32.61% Payout Ratio
Tortoise Energy Infrastructure Corporation is a closed ended equity mutual fund launched and managed by Tortoise Capital Advisors L.L.C. The fund invests in the public equity markets of the United States. It seeks to invest in the stocks of companies operating in the energy infrastructure sector, with an emphasis on those companies that are engaged in transporting, processing, storing, distributing or marketing natural gas, natural gas liquids (primarily propane), coal, crude oil or refined petroleum products, or exploring, developing, managing or producing such commodities. The fund primarily invests in securities of publicly traded Master Limited Partnerships and stocks of companies having a market capitalization greater than $100 million. Tortoise Energy Infrastructure Corporation was formed on October 29, 2003 and is domiciled in the United States.
Earnings Per Share
As for profitability, Tortoise Energy Infrastructure Corporation has a trailing twelve months EPS of $8.57.
PE Ratio
Tortoise Energy Infrastructure Corporation has a trailing twelve months price to earnings ratio of 3.52. Meaning, the purchaser of the share is investing $3.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.39%.
6. Marcus & Millichap (MMI)
30.67% Payout Ratio
Marcus & Millichap, Inc., a brokerage company, provides real estate investment brokerage and financing services to sellers and buyers of commercial real estate in the United States and Canada. The company offers commercial real estate investment sales, financing, research, and advisory services for multifamily, retail, office, and industrial properties, as well as hospitality, self-storage, seniors housing, land, and manufactured housing properties. It also operates as a broker of debt financing for commercial properties. In addition, the company provides various ancillary services, including research, and advisory and consulting services to developers, lenders, owners, real estate investment trusts, high net worth individuals, pension fund advisors, and other institutions. Marcus & Millichap, Inc. was founded in 1971 and is headquartered in Calabasas, California.
Earnings Per Share
As for profitability, Marcus & Millichap has a trailing twelve months EPS of $1.63.
PE Ratio
Marcus & Millichap has a trailing twelve months price to earnings ratio of 21.17. Meaning, the purchaser of the share is investing $21.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.67%.
Yearly Top and Bottom Value
Marcus & Millichap’s stock is valued at $34.50 at 14:23 EST, way below its 52-week high of $41.51 and way above its 52-week low of $27.49.
Moving Average
Marcus & Millichap’s value is way above its 50-day moving average of $30.93 and above its 200-day moving average of $33.65.
